Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
| Image |  |
|---|---|
| Description | scientific article published on 06 August 2018 |
| Author/s |
author: Tony Mok Jacob Silterra |
| Publication date | August 6, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |